Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.067 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |